Health technology assessment: factors affecting the results
Purpose: to identify factors influencing the results of health technology assessment (HTA). Methods. This analysis is based on previously performed clinical (pharmaco-) economic studies in the Republic of Belarus. The primary data analysis methods for inclusion in this publication have been cost-of-...
Gespeichert in:
| Veröffentlicht in: | Kachestvennai͡a︡ klinicheskai͡a︡ praktika H. 3; S. 64 - 72 |
|---|---|
| 1. Verfasser: | |
| Format: | Journal Article |
| Sprache: | Englisch Russisch |
| Veröffentlicht: |
Izdatelstvo OKI
08.12.2021
|
| Schlagworte: | |
| ISSN: | 2588-0519, 2618-8473 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Purpose:
to identify factors influencing the results of health technology assessment (HTA).
Methods.
This analysis is based on previously performed clinical (pharmaco-) economic studies in the Republic of Belarus. The primary data analysis methods for inclusion in this publication have been cost-of-illness analysis (COI). The studies were carried out from 2010 to 2021. All costs are presented in US dollars based on exchange rates at the time of execution. Ranges are presented as maximum and minimum values.
Results.
The analysis of the influence of the stage of the disease, the stage of medical care, the form of release for drugs, the age of the target population for the use of health technology, the source of information on the price of technology on the results of the procedure for assessing medical technology has been performed. Evaluation of the ratio of the results of COI for implementation the clinical protocol and capabilities of the healthcare system (stable angina pectoris, type 2 diabetes mellitus), as well as for a number of special health technologies (hemophilia A; post-stroke spasticity; mantle cell lymphoma; chronic lymphocytic leukemia; chronic myeloid leukemia; lung cancer).
Conclusions.
It can be concluded that there is a need for clear formulations of goals and objectives at the stage of formation of the study design, considering the influence of the position of the researcher, the source of costs, the selected population, form of release (for drugs) on the main clinical and economic indicators and on the subsequent interpretation of the results of HTA. |
|---|---|
| AbstractList | Purpose:
to identify factors influencing the results of health technology assessment (HTA).
Methods.
This analysis is based on previously performed clinical (pharmaco-) economic studies in the Republic of Belarus. The primary data analysis methods for inclusion in this publication have been cost-of-illness analysis (COI). The studies were carried out from 2010 to 2021. All costs are presented in US dollars based on exchange rates at the time of execution. Ranges are presented as maximum and minimum values.
Results.
The analysis of the influence of the stage of the disease, the stage of medical care, the form of release for drugs, the age of the target population for the use of health technology, the source of information on the price of technology on the results of the procedure for assessing medical technology has been performed. Evaluation of the ratio of the results of COI for implementation the clinical protocol and capabilities of the healthcare system (stable angina pectoris, type 2 diabetes mellitus), as well as for a number of special health technologies (hemophilia A; post-stroke spasticity; mantle cell lymphoma; chronic lymphocytic leukemia; chronic myeloid leukemia; lung cancer).
Conclusions.
It can be concluded that there is a need for clear formulations of goals and objectives at the stage of formation of the study design, considering the influence of the position of the researcher, the source of costs, the selected population, form of release (for drugs) on the main clinical and economic indicators and on the subsequent interpretation of the results of HTA. Purpose: to identify factors influencing the results of health technology assessment (HTA). Methods. This analysis is based on previously performed clinical (pharmaco-) economic studies in the Republic of Belarus. The primary data analysis methods for inclusion in this publication have been cost-of-illness analysis (COI). The studies were carried out from 2010 to 2021. All costs are presented in US dollars based on exchange rates at the time of execution. Ranges are presented as maximum and minimum values. Results. The analysis of the influence of the stage of the disease, the stage of medical care, the form of release for drugs, the age of the target population for the use of health technology, the source of information on the price of technology on the results of the procedure for assessing medical technology has been performed. Evaluation of the ratio of the results of COI for implementation the clinical protocol and capabilities of the healthcare system (stable angina pectoris, type 2 diabetes mellitus), as well as for a number of special health technologies (hemophilia A; post-stroke spasticity; mantle cell lymphoma; chronic lymphocytic leukemia; chronic myeloid leukemia; lung cancer). Conclusions. It can be concluded that there is a need for clear formulations of goals and objectives at the stage of formation of the study design, considering the influence of the position of the researcher, the source of costs, the selected population, form of release (for drugs) on the main clinical and economic indicators and on the subsequent interpretation of the results of HTA. |
| Author | Kozhanova, I. N. |
| Author_xml | – sequence: 1 givenname: I. N. orcidid: 0000-0003-4717-5249 surname: Kozhanova fullname: Kozhanova, I. N. organization: State Institution «Republican Scientific and Practical Center for Medical Technologies, Informatization, Management and Economics of Health Care» |
| BookMark | eNo9kMtOwzAURC1UJErpN5AfMMSP2NewQhXQSpXYwNq6sZ02KI2RbRb9e_oAVjMajc7iXJPJGMdAyC2r74SWYO55A0DrhhnKa86ooEpSzS_IlCsGFKQWk0P_O12Rec59W0upm1poPSWPy4BD2VYluO0Yh7jZV5hzyHkXxvJQdehKTLnCrguu9OOmKttQpZC_h5JvyGWHQw7z35yRj5fn98WSrt9eV4unNXVMCU6lQw0ArTHcd8prVL413JjAwAWOTMkWPIOOuyC9Uqp2zHBAZA4NCiXEjKzOXB_x036lfodpbyP29jTEtLGYSu-GYBVqBsor71oljWug9VJyAa4FybVTB5Y-s1yKOafQ_fNYbU9K7dGWPdqyR6VWWCWt5uIHCXhrWA |
| Cites_doi | 10.34883/PI.2020.11.3.018 10.18356/692a9cd1-en 10.15690/pf.v9i5.449 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION DOA |
| DOI | 10.37489/2588-0519-2021-3-64-72 |
| DatabaseName | CrossRef DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2618-8473 |
| EndPage | 72 |
| ExternalDocumentID | oai_doaj_org_article_6a7186d6dcb649c58bd44238cb8427c6 10_37489_2588_0519_2021_3_64_72 |
| GroupedDBID | AAYXX ALMA_UNASSIGNED_HOLDINGS CITATION GROUPED_DOAJ |
| ID | FETCH-LOGICAL-c1632-4ca7888b992df6d7a6db9299e18ce2a164b8d18f2ce4d6660c1928aa1ca9a3633 |
| IEDL.DBID | DOA |
| ISSN | 2588-0519 |
| IngestDate | Fri Oct 03 12:46:25 EDT 2025 Sat Nov 29 05:01:00 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English Russian |
| License | https://www.clinvest.ru/jour/about/editorialPolicies#openAccessPolicy |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c1632-4ca7888b992df6d7a6db9299e18ce2a164b8d18f2ce4d6660c1928aa1ca9a3633 |
| ORCID | 0000-0003-4717-5249 |
| OpenAccessLink | https://doaj.org/article/6a7186d6dcb649c58bd44238cb8427c6 |
| PageCount | 9 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_6a7186d6dcb649c58bd44238cb8427c6 crossref_primary_10_37489_2588_0519_2021_3_64_72 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-12-08 |
| PublicationDateYYYYMMDD | 2021-12-08 |
| PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-08 day: 08 |
| PublicationDecade | 2020 |
| PublicationTitle | Kachestvennai͡a︡ klinicheskai͡a︡ praktika |
| PublicationYear | 2021 |
| Publisher | Izdatelstvo OKI |
| Publisher_xml | – name: Izdatelstvo OKI |
| References | ref13 ref12 ref15 ref14 ref20 ref11 ref10 ref21 ref2 ref1 ref17 ref16 ref19 ref18 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
| References_xml | – ident: ref13 – ident: ref1 – ident: ref4 – ident: ref10 doi: 10.34883/PI.2020.11.3.018 – ident: ref2 – ident: ref3 – ident: ref5 – ident: ref6 – ident: ref20 doi: 10.18356/692a9cd1-en – ident: ref21 – ident: ref7 doi: 10.15690/pf.v9i5.449 – ident: ref9 – ident: ref8 – ident: ref19 – ident: ref18 – ident: ref16 – ident: ref11 – ident: ref17 – ident: ref12 – ident: ref15 – ident: ref14 |
| SSID | ssib044750377 ssj0002874179 |
| Score | 2.1651025 |
| Snippet | Purpose:
to identify factors influencing the results of health technology assessment (HTA).
Methods.
This analysis is based on previously performed clinical... Purpose: to identify factors influencing the results of health technology assessment (HTA). Methods. This analysis is based on previously performed clinical... |
| SourceID | doaj crossref |
| SourceType | Open Website Index Database |
| StartPage | 64 |
| SubjectTerms | орфанные лекарственные средства оценка технологий здравоохранения редкие заболевания таргетные препараты фармакоэкономика |
| Title | Health technology assessment: factors affecting the results |
| URI | https://doaj.org/article/6a7186d6dcb649c58bd44238cb8427c6 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2618-8473 dateEnd: 20241231 omitProxy: false ssIdentifier: ssj0002874179 issn: 2588-0519 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2618-8473 dateEnd: 99991231 omitProxy: false ssIdentifier: ssib044750377 issn: 2588-0519 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELZQhRAL4ine8sBqNXH8hAlQKwZaMQDqZvlVCYQKalNGfjtnJ0RlYmHJYOWi5O6U-86--w6hCxVF9C6d-kc3JYzLkjjLHaEhaJCAiJf7uJ_v5XisJhP9sDLqK9WENfTAjeL6wsLfUwQRvBNMe65cYAABlHeKUekz2XYh9UoyBZ6UWOyKqu2wfM1bSDKN2kqT5ji4RsItTbFXZl_pd4vgNLQkFRGMSPorVK0w-ufQM9xGWy1mxNfNu-6gtflyF22M2lPxPXTV9BLhutsmx7Yj3LzE7UgdbHPpBoQqDKAPQ5q9fKsX--hpOHi8vSPtUATiATpRwrxNWavTmoapCNKK4ADi6FiqNNsLsh-nQqmm1EcWIDcpPGA4ZW3prbaVqKoD1Ju9z-IhwlwHFUGUc-pZ2lnk05LHsoyF8hDX6BEqfr7ffDTcFwZyhqwyk1RmkspMUpmpjGBGgshN0lN3eyKvzgtgUtOa1Pxl0uP_eMgJ2sy2TJUn6hT16vkynqF1_1m_LObn2VvgOvoafAPFSb3j |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Health+technology+assessment%3A+factors+affecting+the+results&rft.jtitle=Kachestvennai%CD%A1a%EF%B8%A1+klinicheskai%CD%A1a%EF%B8%A1+praktika&rft.au=Kozhanova%2C+I.+N.&rft.date=2021-12-08&rft.issn=2588-0519&rft.eissn=2618-8473&rft.issue=3&rft.spage=64&rft.epage=72&rft_id=info:doi/10.37489%2F2588-0519-2021-3-64-72&rft.externalDBID=n%2Fa&rft.externalDocID=10_37489_2588_0519_2021_3_64_72 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2588-0519&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2588-0519&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2588-0519&client=summon |